# An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

> **NCT00109148** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 500 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** MK0364

## Key facts

- **NCT ID:** NCT00109148
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2005-01
- **Final completion:** 2005-02
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2015-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109148, "An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00109148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*